Tower Research Capital LLC (Trc) Edesa Biotech, Inc. Transaction History

Tower Research Capital LLC (Trc)

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.77 - $1.16 $862 - $1,299	-1,120 Reduced 11.62%	8,521 $6,000
Q1 2023 May 09, 2023	BUY	$0.91 - $2.63 $2,906 - $8,400	3,194 Added 49.54%	9,641 $9,000
Q4 2022 Feb 10, 2023	SELL	$0.8 - $8.05 $4,529 - $45,579	-5,662 Reduced 46.76%	6,447 $14,000
Q3 2022 Nov 10, 2022	BUY	$1.39 - $9.94 $11,954 - $85,484	8,600 Added 245.08%	12,109 $11,000
Q2 2022 Aug 15, 2022	BUY	$1.47 - $2.94 $776 - $1,552	528 Added 17.71%	3,509 $6,000
Q1 2022 May 12, 2022	BUY	$2.72 - $5.97 $7,229 - $15,868	2,658 Added 822.91%	2,981 $9,000
Q4 2021 Feb 14, 2022	SELL	$5.17 - $8.65 $15,267 - $25,543	-2,953 Reduced 90.14%	323 $2,000
Q3 2021 Nov 15, 2021	BUY	$4.2 - $11.92 $13,759 - $39,049	3,276 New	3,276 $24,000

Ticker EDSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,462,300
Market Cap $66.3M
Description
Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress s...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.